Flow of samples and information for newborn screening in a model of publicprivate

Similar documents
Attachment 1. Newborn Screening Program Description

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

Sending and Receiving Newborn Screening Results in Indiana: The HIE Perspective

Positive Newborn Screens: What do you do next?

Newborn Screening: Focus on Treatment

Saving Lives Through Newborn Screening: Making the Most of a Simple Blood Test

Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory

For Your Baby s Health Department of Health

Early Intervention: The Importance of Newborn Screening

NEWBORN METABOLIC SCREEN, MINNESOTA

The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot

Newborn Screening: Blood Spot Disorders

Comprehensive cost-utility analysis of newborn screening strategies Carroll A E, Downs S M

Newborn Screening in Manitoba. Information for Health Care Providers

Screening Newborns for Congenital Disorders

Annual Report Calendar Year 2015

Analytes, instrumentation and software for neonatal screening. Complete solutions for screening newborns

Sequencing in Newborn Screening Introduction and Background

RESULTS SPECIFICATION

Newborn Screening in Washington State Saving lives with a simple blood spot

Annual Report Calendar Year 2014

Assessing Mothers Knowledge of the Wisconsin Newborn Screening Program. Sara Wolfgram UW Master of Public Health Symposium August 11, 2006

Health Chapter ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE

Institute of Medicine Workshop May 24, 2010 Challenges and Opportunities in Using Newborn Screening Samples for Translational Research

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

A Guide for Prenatal Educators

NEWBORN SCREENING IN JAPAN

Annual Report to the Newborn Screening Ontario Advisory Council Calendar Year 2017

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN

MI Newborn Screening Program: An Overview of Follow-up & Case Management for Sickle Cell Conditions

So Much More Than The PKU Test

Purpose. Newborn Screening- UC 260. What is NBS? What isn t NBS? History. History 2

Health and Wellness for all Arizonans. azdhs.gov

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Current Newborn Screening Practices Across the Globe: Can We Standardize?

Washington State Newborn Screening

Secretary's Advisory Committee on Heritable Disorders in Newborns and Children May 13, 2009

For the Ongoing Management of Babies under 1 year old.

Newborn Screening Advisory Committee

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

Newborn Bloodspot Screening Information for parents

Newborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

Newborn Bloodspot Screening Information for parents

Development of a Multiplex CYP21A2 Genotyping Assay for Congenital Adrenal Hyperplasia Screening

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Inborn Errors of Metabolism From Neonatal Screening to Metabolic Pathways

Message Mapping Guide (MMG) Development Update: Status of Work, Lessons Learned, and Enhancements

EHDI: An Amazing Journey

THE UTAH STATE GENETICS PLAN MAY 2002

Reliable. results. efficiently. for CH, galactosemia, CAH and CF screening

Short Term Follow Up Tandem Mass Spectrometry Workshop Agenda

Newborn Screening Issues and Answers Workshop: Laboratory Health Information Exchange November 1-2, Utah Department of Health

Newborn Screening Manual

Trends across the country. Indiana Early Hearing Detection 4/13/2015

The findings and conclusions in this presentation

What is the Connection? EHDI and HIT. Lura Daussat, MPH April 15, 2014

SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure

Annual Report on the External Quality Assessment Scheme for Biochemical Genetics in Korea (2014)

Quality Performance Measurement and Use of Health Information Technology in Critical Access Hospitals

Green Amber Red Assurance Level

Topeka Indiana LaGrange/ Elkhart Counties Indiana Plain Church Population over 46,000

QA/QC 2 Strategies to Reduce False Positives and False Negatives (Part 2)

A. Executive Summary:

Saudi Population & Genetic Diseases

2015 Annual Report for New Mexico s Newborn Screening (NBS) Program

How MS/MS Revolutionized Newborn Screening

Testing for Genetic Disorders that Cause Brain Damage

Indiana Early Hearing Detection and Intervention (EHDI)

Mississippi Newborn Screening Report

Development of an Electronic Notification System for Influenza like Illness Sentinel Surveillance. Mehnaz Adnan

Newborn Screening for Severe Combined Immunodeficiency (SCID) by Quantifying T-cell Receptor Excision Circles (TREC)

HL7 CDS Project Update

Newborn Metabolic Screening Programme. Annual Report

NEWBORN SCREENING FOR SICKLE CELL DISEASE Progress Towards Improved Outcomes for Children and Families

ARTICLE. The Magnitude and Challenge of False-Positive Newborn Screening Test Results. hereditary metabolic diseases

Newborn Screening. Helping babies start life healthy. Minnesota Newborn Screening Program

Slide 1: Newborn Bloodspot Screening for Medium-chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY

Workshop Overview. The Problem. National Milestones. The Registry Solution. Benefits of Registry/Managed Care Collaboration

Newborn Metabolic Screening Programme

Pilot Study of Newborn Screening (NBS) for Inborn Errors of Metabolism (IEM) in Collaboration with Department of Health and Hospital Authority

NEWBORN SCREENING in Massachusetts: Answers for you and your baby

Piero Rinaldo, Si Houn Hahn, Dietrich Matern. Biochemical Genetics Laboratory Mayo Clinic College of Medicine Rochester, MN

Kansas Successful Strategies in Reducing Loss to Follow-Up/Loss to Documentation

Screening for Phenylketonuria: A Literature Update for the U.S. Preventive Services Task Force

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

Chapter 5 Newborn Screening for Congenital Disorders

Newborn Genetic Testing & Surveillance System

A Pilot Study on an Expanded Newborn Screening Program in Palestine. Phaseп

NATIONAL NEWBORN SCREENING REPORT Final Report: February, 2003

History of Screening for CF and CH in New Zealand. Dianne Webster Diane Casey Kathy Bendikson Richard MacKay Paul Hofman

SFDPH Responds to Hepatitis C: Strategic Directions for and Beyond

Improving Communication of Negative Newborn Screening Results. Whitney Thompson MPhil Amy Gaviglio MS, CGC Susan Berry MD

Newborn Screening in Japan: Restructuring for the New Era

Risk Factors for Late-Onset Hearing Loss in Children

aycan workflow HIS/RIS/PACS integration with HL7 and DICOM

Transcription:

Flow of samples and information for newborn screening in a model of publicprivate partnership Marzia Pasquali, PhD, FACMG Associate Professor of Pathology, University of Utah Medical Director, Biochemical Genetics and Newborn screening, ARUP Laboratories

Newborn screening is a program The efficiency and effectiveness of a newborn screening program is dependent upon the smooth integration of sample collection, laboratory testing, follow-up, diagnosis, timely treatment, and tracking of outcomes.

PILOT PROJECT (2003-2005) Representatives from the Utah Department of Health, ARUP Laboratories, and the Metabolic Center at the University of Utah designed a pilot project to demonstrate feasibility of a collaborative approach for expanding newborn screening. Each entity in this collaborative project was contributing its specific expertise.

Primary Childrens Medical Center University of Utah School of Medicine Utah Department of Health University Hospital Connor Road 1 Mile ARUP All collaborating entities are in close physical proximity Research Park Chipeta Way

UTAH Newborn screening program Education Evaluation Clinical care Follow-up

PILOT PROJECT (2003-2005) Only one hospital was included (limited number of samples) Demographic data were entered from the Department of Health into a Microsoft Access database and transmitted to ARUP Laboratories database in flat files. From ARUP the information were sent back to the DoH with additional fields: AMINO ACID PROFILE, ACYLCARNITINE PROFILE. The results entered in these fields were either: NORMAL, or ABNORMAL. The ABNORMAL result was always associated with a comment indicating the abnormality, the significance, and the action to be taken.

Newborn Screening in Utah (2006) PKU Congenital Hypothyroidism Galactosemia Hemoglobinopathies Newborn Hearing Screening MCAD Deficiency MSUD Homocystinuria Biotinidase Congenital adrenal hyperplasia Others detectable by MS/MS

NEWBORN SCREENING WORKFLOW Hospital State Health Lab GALT, Thy, CAH Biot, SS Metabolic Specialist Medical Home Baby is born ARUP at the Univ of Utah Expanded screen by MS/MS Patient & Family

NEWBORN SCREENING WORKFLOW

Identifiers: 1) Kit Number (unique to the baby) 2) Accession number (unique to the specimen)

NBS Excel Spreadsheet (NBR*.DAT)

NBO*.DAT Orders HL7 HL7 HL7 PathNet HL7 OHR Interface engine Orion Health Rhapsody ANSR

HL7 MESSAGES ORDER MESSAGE RECEIVED MSH ^~\& NBSL 11872 2007MMDD123808 ORM^O01 159557 P 2.3.1 PID 1 351A745 DOE^JANE 2007MMDD000000 F ORC NW OBR 1 304152 81260^NBS^2 2007MMDD000000 S1440156200709 OBX 1 NM 80192^NBS-TMS BIRTH WEIGHT IN GRAMS 3671

NBR*.DAT NBO*.DAT Locate matches Active.MDB Access database Found match FTP inbs*.dat HL7 result file

FTP inbs*.dat HL7 result file HL7 OHR Results HL7 HL7 PathNet HL7 OHR

HL7 MESSAGES RESULT MESSAGE SENT BACK TO DoH. MSH ^~\& ARUP 11872 2007MMDD083600 ORU^R01 2007MMDD08372461 P 2.3 PID 1 S1440156200709 351A745 DOE^JANE^ 2007MMDD F OBR 1 304593 0714417508 81262^NEWBORN SUPPLEMENTAL 2INTERPS 2007MMDD143900 S1440156200709 F OBX 1 ST 80048^AMINO ACID PROFILE NORMAL OBX 2 ST 80049^ACYLCARNITINE PROFILE NORMAL

ABNORMAL RESULTS Abnormal results are transmitted electronically The follow-up program is alerted electronically through their laboratory information system Abnormal results are also called by phone

Confirmatory tests Abnormal screening results are followed up with confirmatory tests Contract with the State includes these tests Web access to results

ARUP CONNECT

ARUP CONNECT

Diagnostic time Average time from Date of Birth to diagnosis: PKU 5.5 days MCAD deficiency 5.3 days

System monitoring For every step in the process there are checks developed to monitor sample processing and data transfer. Follow-up of abnormal results are monitored at the DoH and ARUP Laboratories to assure prompt action.

SUMMARY In Utah, the public-private partnership has allowed expansion of the newborn screening program, with each component providing its specific expertise. Electronic data exchange allows fast communications among different entities. The collaboration improves diagnostic time and patients care.

THANK YOU! ARUP NBS Laboratory ARUP IT Department

Department of Health Steven Tuttle Barbara Jepson Fay Keune Norman Brown Harper Randall, MD Pat Luetdke, MD, PhD THANK YOU! University of Utah Nicola Longo, MD, PhD